ROCKVILLE, Md., Jan. 7, 2015 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that a member of the company's senior management team will participate in the following investor conferences in January 2015:
- 33rd Annual J.P. Morgan Healthcare Conference
January 12, 2015
Presentation: 8:00AM Pacific
- Noble Financial Capital Markets' 11th Annual Investor/Equity Conference
January 20, 2015
Presentation: 3:00PM Eastern
The company will be webcasting its participation in these conferences, which may include a discussion of the company's recent business developments as well as its most recently reported financial results and guidance. The webcasts will be available both live and by replay, accessible from the Emergent website www.emergentbiosolutions.com under "Investors."
About Emergent BioSolutions Inc.
Emergent BioSolutions is a specialty biopharmaceutical company seeking to protect and enhance life by offering specialized products to healthcare providers and governments to address medical needs and emerging health threats. Additional information about the company may be found at www.emergentbiosolutions.com.
Follow us on twitter: @emergentbiosolu.
CONTACT: Investors Contact: Robert G. Burrows Vice President, Investor Relations 301-795-1877 BurrowsR@ebsi.com Media Contact: Tracey Schmitt Vice President, Global Public Affairs and Corporate Responsibility 301-795-1800 SchmittT@ebsi.com
Source:Emergent BioSolutions Inc.